Abbott Laboratories buy Piper Jaffray Companies
Start price
19.09.24
/
50%
€103.70
Target price
19.09.25
€117.65
Performance (%)
12.09%
End price
20.09.25
€116.24
Summary
This prediction ended on 20.09.25 with a price of €116.24. The BUY prediction by Piper_Jaffray_Compan finished with a performance of 12.09%. A total of €1.08 was paid as dividends for this prediction. Piper_Jaffray_Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -4.137% | -4.137% | -23.015% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by Piper_Jaffray_Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler Companies. They set an "overweight" rating and a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von Piper_Jaffray_Compan gewählte maximale Laufzeit wurde überschritten